Davita (NYSE:DVA) Receives Hold Rating from SunTrust Banks
SunTrust Banks reissued their hold rating on shares of Davita (NYSE:DVA) in a research report report published on Wednesday, The Fly reports. They currently have a $68.00 price target on the stock. SunTrust Banks also issued estimates for Davita’s Q1 2020 earnings at $1.18 EPS, Q2 2020 earnings at $1.35 EPS, Q3 2020 earnings at $1.39 EPS, Q4 2020 earnings at $1.43 EPS and FY2020 earnings at $5.35 EPS.
A number of other research firms have also recently issued reports on DVA. William Blair reiterated a buy rating on shares of Davita in a research note on Thursday, June 20th. UBS Group lowered their price target on shares of Davita from $61.00 to $60.00 and set a neutral rating for the company in a report on Thursday, August 22nd. TheStreet raised shares of Davita from a c+ rating to a b- rating in a report on Wednesday, July 24th. ValuEngine lowered shares of Davita from a hold rating to a sell rating in a report on Tuesday, August 20th. Finally, Robert W. Baird lowered shares of Davita from an outperform rating to a neutral rating and lowered their price target for the company from $70.00 to $65.00 in a report on Friday, July 26th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $67.31.
NYSE:DVA opened at $61.86 on Wednesday. Davita has a 1 year low of $43.40 and a 1 year high of $79.11. The firm has a 50 day moving average of $58.29 and a 200-day moving average of $54.38. The company has a current ratio of 1.12, a quick ratio of 1.10 and a debt-to-equity ratio of 1.90. The stock has a market capitalization of $9.67 billion, a P/E ratio of 17.33, a price-to-earnings-growth ratio of 0.60 and a beta of 1.59.
Institutional investors have recently modified their holdings of the stock. Rehmann Capital Advisory Group increased its holdings in shares of Davita by 467.3% in the first quarter. Rehmann Capital Advisory Group now owns 556 shares of the company’s stock valued at $30,000 after purchasing an additional 458 shares in the last quarter. Clearbridge Investments LLC grew its holdings in Davita by 63.5% during the 1st quarter. Clearbridge Investments LLC now owns 798 shares of the company’s stock worth $43,000 after acquiring an additional 310 shares during the period. CSat Investment Advisory L.P. grew its holdings in Davita by 54.0% during the 1st quarter. CSat Investment Advisory L.P. now owns 895 shares of the company’s stock worth $49,000 after acquiring an additional 314 shares during the period. Employers Holdings Inc. acquired a new stake in Davita during the 2nd quarter worth $56,000. Finally, Neo Ivy Capital Management acquired a new stake in Davita during the 2nd quarter worth $61,000. 91.47% of the stock is owned by institutional investors and hedge funds.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.